Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14800040 | 0.81 | KMT2A (0.48) | KMT2AMEN1MAPTMDM2MCL1 | |
| SCHEMBL14799893 | 0.80 | POLB (0.40) | KMT2ALMNAMEN1MAPTHTT | |
| SCHEMBL14799716 | 0.78 | NPC1 (0.43) | KMT2AL3MBTL1LMNAMEN1MAPT | |
| SCHEMBL14806791 | 0.75 | MAPT (0.47) | KMT2ALMNAMEN1MAPTHTT | |
| SCHEMBL14799791 | 0.70 | KDM4E (0.44) | KMT2ALMNAMEN1MAPTHTT | |
| SCHEMBL14799741 | 0.69 | NPC1 (0.46) | KMT2AL3MBTL1LMNAMEN1MAPT | |
| SCHEMBL16401994 | 0.67 | MEN1 (0.42) | KMT2ALMNAMEN1MAPTHTT | |
| SCHEMBL11537780 | 0.66 | GAA (0.57) | KMT2AL3MBTL1LMNAMEN1MAPT | |
| SCHEMBL16885012 | 0.64 | HPGD (0.47) | KMT2ALMNAMEN1MAPTHTT | |
| SCHEMBL14799643 | 0.64 | SMPD1 (0.51) | KMT2ALMNAMEN1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9382424-B2 | Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| US-9382424-B2 | Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| US-9382424-B2 | Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-03-28 | — | — | US | disclosed |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-03-28 | — | — | US | disclosed |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | SUN2, NES, CRY1 | KMT2A 645/4885L3MBTL1 2873/4885LMNA 792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.